CSTL
Castle Biosciences, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$32.91
+0.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.14x
- Price / sales
- 2.81x
- Price / cash flow
- 23.58x
Enterprise value
- Enterprise value
- $775.2M
- EV / sales
- 2.17x
- EV / EBITDA
- -239.56x
- EV / EBIT
- -24.14x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026